Name | triammonium [[(E)-4-hydroxy-3-methyl-but-2-enoxy]-oxido-phosphoryl] phosphate |
---|
Description | HDMAPP triammonium is a potent phosphoantigen in the ammonium form and the pyrophosphate form of (E)-HDMAPP. HDMAPP is also a potent activator of γδ T cells and can induce T cell stimulation in vitro (EC50=0.39 nM, TNF-α)[1]. |
---|---|
Related Catalog | |
Target |
TNFRSF1A |
In Vitro | HDMAPP triammonium (化合物 3E) (2 μM) 增加原代多克隆人 Vγ9Vδ2 T 细胞中的 TNF-α 释放水平,并具有刺激性生物活性[1]。 |
In Vivo | HDMAPP triammonium (化合物 3E) (0.02-2.5 mg/kg;静脉注射;15 天) 显着增加食蟹猴模型中的 γδ 细胞[1]。 Animal Model: Nonhuman Primate Model in Cynomolgus[1] Dosage: 0.02 mg/kg, 0.1 mg/kg, 0.5 mg/kg, 2.5 mg/kg Administration: Intravenous injection; once with daily s.c. low doses IL-2 to sustain γδ-T-cell proliferation, for 15 days Result: Significantly increased γδ-cells in vivo at 0.02 mg/kg. Reached maximal effect at 2.5 mg/kg. |
References |
Molecular Formula | C5H21N3O8P2 |
---|---|
Molecular Weight | 313.183 |
Exact Mass | 313.080383 |